[Autologous serum utilization in patients with lacrimal hyposecretion and persistent epithelial defects of cornea--clinical study].
Autologous serum was supposed to be efficient in the treatment of keratoconjunctivitis sicca and persistent epithelial defects. 14 of 24 eyes of patients with keratoconjunctivitis sicca improved fluorescein and rose Bengal scores. 3 of 6 eyes with persistent epithelial defects healed completely after this treatment and 2 improved fluorescein and rose bengal scores. All patients had been unsuccessfully treated with conventional treatment. Allergic or immune adverse reactions were not present and economical benefit was appreciated by some patients with poor socioeconomic condition.
Nistor
Marius
M
Spitalul Universitar CF Cluj-Napoca. MC_NISTOR@HOTMAIL.COM
Nistor
Crina
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001798:Blood Proteins / Q000008:administration & dosage*; D001804:Blood Transfusion, Autologous; D003316:Corneal Diseases / Q000473:pathology / Q000628:therapy; D019573:Epithelium, Corneal / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
D001798:Blood Proteins; D009883:Ophthalmic Solutions